Roto-Rooter (CHE) - Price-to-Projected Revenue Ratio

Corporate emblem and logo of VITAS Healthcare (CHE)

Despite the healthcare labor shortage, Chemed Corporation (CHE) retains its staff through a bonus system. Revenues are based on the synergy between VITAS palliative care and the Roto-Rooter service. The strategy relies on emergency demand in both niches. The forward P/S trajectory demonstrates a market balance of value to sales, where the latest value is recorded as 2.10, allowing for an assessment of the asset's current discount.

CHE Chemed: Market Cap to Future Revenue Ratio in the range 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for Chemed (CHE)

- market price and analyst price targets:
Price Chart VITAS Healthcare|CHE - Fair Value Consensus
- market capitalization indicators:
Market Value Chemed|CHE - Full Business Value
- book value of equity indicators:
Net Assets per Single Share Chemed|CHE - Total Stockholders' Equity|Market Value to Book Value Ratio chemed.com|CHE - Aggregate Asset Value
- debt burden and liquidity indicators:
Total Debt to Capital Chemed Corporation|CHE - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Chemed Corporation|CHE - Company Cumulative Indebtedness|Debts to Book Capitalization VITAS Healthcare|CHE - Long-Term Debt Volume|Company Short-Term Debt Chemed|Quick Liquidity chemed.com
- business earnings and investment ratios data:
CHE - Company Profit|Projected Future Earnings Chemed Corporation|CHE - Price to Earnings Ratio|Forward P/E Multiple Chemed Corporation|CHE - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Chemed Corp|CHE - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Chemed|CHE - Net earnings per share for the last 12 months|Quarterly EPS earnings growth chemed.com|CHE - Earnings growth in current year|Net earnings per share growth forecast for next year Chemed Corporation
- revenue and sales details:
CHE - Company Sales Revenue|Projected Sales Volume chemed.com|CHE - Price to Sales|Forward P/S Multiple Roto-Rooter
General company analysis:Chemed Corp CHE
Product sample of chemed.com

For Chemed Corporation (CHE), which combines a stable plumbing sector with Medicare-dependent hospices, the company's forward P/S reflects the market valuation of expected revenue adjusted for regulatory risks. Daily calculation of this ratio allows for tracking the real-time assessment of price relative to liquidity, turning the company's forward P/S into an indicator of asset overbought conditions or a signal to identify an entry point.

Analysis of competing companies

Forward P/S Multiple ELV (Anthem)|Dignity Memorial (SCI) - Market Cap to Future Revenue Ratio|ENSG - Price-to-Projected Revenue Ratio|Forward Price to Sales BFAM (Bright Horizons)|BrightSpring Corp (BTSG) - Price-to-Projected Revenue Ratio|Alignment Healthcare, Inc. - Forward Price to Sales|ADUS (Addus HomeCare Corp) - Forward P/S Multiple|Market Cap to Projected Revenue BKD (Brookdale Senior Living Inc)|Forward Price-to-Revenue Multiple NHC (National HealthCare)|PACS Group, Inc. - Market Cap to Projected Revenue|Price-to-Projected Revenue Ratio Guardian Pharmacy Services, Inc. GRDN|Forward Price to Sales AVAH|LTC REIT - Forward P/S Multiple|HCSG: Price-to-Projected Revenue Ratio|MATW: Forward P/S Multiple|CSV - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple INNV|Price-to-Projected Revenue Ratio SNDA|Forward P/S Multiple EHAB|EJH - Market Cap to Future Revenue Ratio|Forward P/S Multiple AMED (Amedisys Inc)